What is BioLineRx Ltd?
, a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 4.80M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.